Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Oligo (dT) 25 Beads: Practical Guide for Eukaryotic mRNA Iso

    2026-06-08

    Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Purification

    What This Product Solves

    Efficient purification of eukaryotic mRNA is a prerequisite for sensitive transcriptomic analysis, functional genomics, and molecular diagnostics. Oligo (dT) 25 Beads are monodisperse superparamagnetic beads functionalized with covalently attached oligo (dT) sequences. They enable direct, rapid, and selective capture of polyadenylated (polyA) mRNA from complex biological samples—including total RNA, cell lysates, and tissue extracts from animals or plants. By exploiting the affinity between the polyA tail and oligo (dT), these beads streamline workflows for first-strand cDNA synthesis, RT-PCR, library construction, and other downstream applications where mRNA integrity and purity are critical.

    Compared to column-based methods, superparamagnetic bead-based protocols eliminate the need for centrifugation and enable scalable, automation-friendly mRNA purification in multi-sample contexts. This is especially valuable for high-throughput gene expression profiling, next-generation sequencing, and clinical research where reproducibility and minimal sample loss are priorities.

    For an in-depth discussion of how magnetic bead-based mRNA purification impacts functional genomics, see the article "Oligo (dT) 25 Beads: Molecular Precision in mRNA Purification", which addresses core molecular principles and advanced workflow integration.

    Protocol Parameters

    • Bead concentration | 10 mg/mL | Product specification | Ensures consistent polyA tail mRNA capture capacity per reaction; do not dilute beyond this unless optimizing for sample input differences | Product dossier
    • Storage temperature | 4 °C | Product specification | Maintains integrity and superparamagnetic properties of beads for 12–18 months; avoid freezing to prevent clumping and loss of binding efficiency | Product dossier
    • Sample type compatibility | Eukaryotic total RNA, cell, or tissue lysates | Workflow recommendation | Effective for animal and plant samples; not suitable for non-polyadenylated RNA, prokaryotic RNA, or degraded RNA where polyA tails are lost | Workflow best practices
    • Elution volume | 20–50 μL (typical) | Workflow recommendation | Use minimal elution volume to maximize mRNA concentration; adjust based on downstream assay requirements | Workflow best practices
    • Binding time | 10–30 minutes (typical) | Workflow recommendation | Sufficient for complete hybridization between oligo (dT) and polyA tails; longer binding may increase yield for low-abundance targets | Workflow best practices

    Workflow Setup and QC Checklist

    • Pre-equilibrate Oligo (dT) 25 Beads at room temperature before use. Vortex gently to resuspend beads fully, as beads may settle during storage.
    • Prepare total RNA or lysate in a nuclease-free environment. Quantify RNA input and assess integrity (e.g., via Bioanalyzer or agarose gel) to ensure polyA tail preservation.
    • Combine beads and sample according to input recommendations, ensuring bead excess for high-yield capture when working with high RNA inputs.
    • Perform binding at room temperature or as specified in your protocol; gentle mixing (e.g., inversion or rotation) improves hybridization efficiency.
    • Use a magnetic rack for rapid bead pelleting during washing steps. Wash thoroughly with recommended buffers to remove non-mRNA contaminants.
    • Elute mRNA in nuclease-free water or low-salt buffer. Minimize elution volume to maintain concentration for downstream use.
    • QC the eluate for mRNA integrity and yield using spectrophotometry, fluorometry, or capillary electrophoresis. Confirm absence of ribosomal or genomic RNA contamination if required for your application.
    • Store unused beads at 4 °C and avoid repeated freeze-thaw cycles.

    For additional technical details and a benchmarking perspective, the article "Oligo (dT) 25 Beads: Benchmark Magnetic Bead-Based mRNA Purification" compares APExBIO's solution to other market options and discusses integration into RT-PCR and sequencing workflows.

    Common Failure Modes and Fixes

    • Low mRNA yield: Confirm bead resuspension and thorough mixing during binding. Increase bead amount for high-input samples, or extend binding time for low-abundance mRNA.
    • RNA degradation: Always use RNase-free reagents and consumables. Assess sample integrity prior to binding; degraded RNA may lack intact polyA tails and reduce recovery.
    • Bead clumping or poor magnetic separation: Do not freeze beads. Store at 4 °C and vortex gently before use. If clumping persists, pass beads through a narrow-gauge pipette tip to disperse.
    • Contaminating DNA or ribosomal RNA: Increase wash steps or optimize buffer stringency. Consider incorporating a DNase or rRNA depletion step upstream if needed.
    • Inhibition in downstream assays: Ensure complete removal of wash buffers and detergents before elution. If inhibition persists, perform an additional ethanol precipitation or buffer exchange.

    Scope and Limitations

    • Designed for selective isolation of polyA-tailed eukaryotic mRNA. Not suitable for non-polyadenylated RNAs (e.g., prokaryotic mRNA, rRNA, tRNA) or for applications requiring capture of total RNA.
    • Performance is contingent on sample integrity; degraded or chemically modified polyA tails will compromise binding efficiency.
    • Superparamagnetic bead-based methods are compatible with automation and high-throughput protocols but require magnetic separation infrastructure.
    • Bead storage is constrained to 4 °C; freezing or prolonged exposure to room temperature may reduce functionality.
    • Downstream application compatibility (e.g., RT-PCR, first-strand cDNA synthesis) depends on thorough removal of contaminants and proper mRNA elution.
    • No direct evidence available for use in prokaryotic systems or for non-standard sample types outside the described animal or plant origin.

    Conclusion

    Oligo (dT) 25 Beads provide a robust, scalable platform for eukaryotic mRNA isolation via polyA tail capture, supporting a wide range of downstream molecular biology applications. When used as directed and integrated with careful workflow controls, these superparamagnetic beads enable reproducible isolation of high-quality mRNA suitable for RT-PCR, library preparation, and more. For full technical details or ordering information, consult the Oligo (dT) 25 Beads product page at APExBIO.